Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
5
×
Tags
biotech
boston blog main
boston top stories
hepatitis b
5
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
amgen
boulder/denver blog main
boulder/denver top stories
cancer
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
purdue pharma
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
alexion pharmaceuticals
alnylam pharmaceuticals
astrazeneca
biotech ipos
boehringer ingelheim
boston
deals
What
bio
drug
roundup
medicines
research
way
abbvie’s
acquisitions
advantages
bar
barbecuing
biggest
biotechs
brings
build
buy
camping
cardiologist
caught
causing
center
central
ceo
check
cholesterol
cns
company’s
conference
daniel
day
debut
dicerna
disease
disorder
drugs
dyne’s
emerged
expect
eye
flop
Language
unset
5
×
Current search:
photo
×
unset
×
" hepatitis b "
×
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More
